A new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents

About

This technology utilizes a new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents and/or the immune system to control the growth and persistence of microorganisms in medical settings and aqueous systems. RB567

Key Benefits

(1) Biodegradable. (2) Non-toxic. (3) Approach capable of targeting resistant biofilm cells. (4) Mechanism of action and experimental data suggest very low likelihood of the emergence of resistance. (5) Can be used synergistically with other antimicrobials and dispersion-inducing compounds.

Applications

Targeting chronic biofilm infections. Disinfection of bacterial biofilms on surfaces.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations